New research from the University of Cincinnati demonstrates how specially engineered bacteria taken orally can operate as a delivery system for antiviral therapies and vaccines.
The research, led by Nalinikanth Kotagiri, PhD, was recently published in the journal Gut Microbes.
Study background
Kotagiri’s lab focuses on engineering probiotic bacteria to accomplish a wide variety of functions, from breaking down cancer’s defenses to imaging and diagnosing lung infections.
A few years ago,…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply